Correlates of receiving recommended adolescent vaccines among adolescent females in North Carolina

Figures & data

Figure 1 Adolescent vaccines received as reported by parents (n = 647). Figure does not show 51 parents (8%) who reported their daughters had not received any of these vaccines. Tetanus booster vaccine includes tetanus, diphtheria and acellular pertussis (Tdap) vaccine or tetanus and diphtheria toxoids (Td) vaccine. Meningococcal vaccine includes meningococcal conjugate vaccine (MCV4) or meningococcal polysaccharide vaccine (MPS V4).

Table 1 Characteristics of parents and their daughters in the follow-up study (n = 647)

	n (%)
Daughter Characteristics
Age (years)
11–12	106 (16)
13–15	194 (30)
16–20	347 (54)
Health Insurance
None	34 (5)
Public Only	81 (13)
Private	532 (82)
Had a Preventive Care Visit in Last Year
No	110 (17)
Yes	537 (83)
Parent Characteristics
Age (years)
<40	133 (21)
40+	514 (79)
Sex
Female	609 (94)
Male	38 (6)
Race
Non-Hispanic White	479 (74)
Non-Hispanic African American	131 (20)
Other	37 (6)
Education Level
High School or Less	122 (19)
Some College or More	525 (81)
Household Characteristics
Income
<$60,000	259 (40)
$60,000+	361 (56)
Not Reported	27 (4)
Urbanicity
Rural	321 (50)
Urban	326 (50)

Table 2 Correlates of receiving recommended adolescent vaccines (tetanus booster,a meningococcal,b and HPV vaccines) (n = 647)

		Total number of vaccines received
	None n (%)	One n (%)	Two n (%)	Three n (%)	Bivariate OR (95% CI)	Multivariate OR (95% CI)
Daughter Characteristics
Age (years)
11–12	15(14)	49(46)	31(29)	11(10)	ref.	ref.
13–15	16 (8)	81 (42)	69 (36)	28 (14)	1.57 (1.01–2.45)*	1.70 (1.09–2.64)*
16–20	20 (6)	143 (41)	112 (32)	72 (21)	1.97 (1.31–2.97)**	2.28 (1.51–3.44)**
Health Insurance
None	4 (12)	16 (47)	9 (27)	5 (15)	ref.	—
Public Only	9 (11)	32 (40)	26 (32)	14 (17)	1.32 (0.62–2.80)	—
Private	38 (7)	225 (42)	177 (33)	92 (17)	1.45 (0.76–2.80)	—
Had a Preventive Care Visit in Last Year
No	25 (23)	61 (56)	19 (17)	5 (5)	ref.	ref.
Yes	26 (5)	212 (39)	193 (36)	106 (20)	4.97 (3.26–7.60)**	4.81 (3.14–7.34)**
Parent Characteristics
Age (years)
<40	7 (5)	66 (50)	43 (32)	17 (13)	ref.	—
40+	44 (9)	207 (40)	169 (33)	94 (18)	1.20 (0.85–1.70)	—
Sex
Female	49 (8)	253 (42)	198 (33)	109 (18)	ref.	—
Male	2 (5)	20 (53)	14 (37)	2 (5)	0.71 (0.40–1.26)	—
Race
Non-Hispanic White	37 (8)	205 (43)	152 (32)	85 (18)	ref.	—
Non-Hispanic African American	11 (8)	57 (44)	45 (34)	18 (14)	0.89 (0.63–1.27)	—
Other	3 (8)	11 (30)	15 (41)	8 (22)	1.46 (0.79–2.70)	—
Education Level
High School or Less	19 (16)	57 (47)	35 (29)	11 (9)	ref.	ref.
Some College or More	32 (6)	216 (41)	177 (34)	100 (19)	2.10 (1.44–3.06)**	1.90 (1.29–2.80)**
Household Characteristics
Income
<$60,000	23 (9)	117 (45)	84 (32)	35 (14)	ref.	ref.
$60,000+	25 (7)	144 (40)	122 (34)	70 (19)	1.37 (1.02–1.84)*	1.15 (0.85–1.57)
Not Reported	3 (11)	12 (44)	6 (22)	6 (22)	1.06 (0.50–2.27)	0.85 (0.40–1.83)
Urbanicity
Rural	25 (8)	136 (42)	108 (34)	52 (16)	ref.	—
Urban	26 (8)	137 (42)	104 (32)	59 (18)	1.03 (0.78–1.37)	—

Note: Percents may not sum to 100% due to rounding. The multivariate ordinal logistic model did not include variables with dashes (—). HPV, human papillomavirus; OR, odds ratio; CI, confidence interval; ref., referent group.

a Tetanus, diphtheria and acellular pertussis (Tdap) vaccine or tetanus and diphtheria toxoids (Td) vaccine.

b Meningococcal conjugate vaccine (MCV4) or meningococcal polysaccharide vaccine (MPS V4).

* p < 0.05,

** p < 0.01.

Table 3 Correlates of receiving each recommended adolescent vaccine (n = 647)

	Tetanus booster vaccinea		Meningococcal vaccineb		HPV vaccine
	n (%)	Multivariate OR (95% CI)	n (%)	Multivariate OR (95% CI)	n (%)	Multivariate OR (95% CI)
Daughter Characteristics
Age (years)
11–12	85 (80)	ref.	34 (32)	1.52 (0.88–2.63)	25 (24)	ref.
13–15	170 (88)	1.87 (0.96–3.62)	58 (30)	ref.	75 (39)	2.31 (1.32–4.04)**
16–20	310 (89)	2.00 (1.09–3.67)*	142 (41)	1.68 (1.13–2.50)*	131 (38)	2.04 (1.21–3.44)**
Health Insurance
None	30 (88)	—	8 (24)	—	11 (32)	—
Public Only	71 (88)	—	28 (35)	—	27 (33)	—
Private	464 (87)	—	198 (37)	—	193 (36)	—
Had a Preventive Care Visit in Last Year
No	81 (74)	ref.	24 (22)	ref.	9 (8)	ref.
Yes	484 (90)	2.94 (1.74–4.95)**	210 (39)	1.44 (0.86–2.43)	222 (41)	7.24 (3.55–14.78)**
Received Tetanus Booster Vaccine a
No	N/A	N/A	14 (17)	ref.	22 (27)	—
Yes	N/A	N/A	220 (39)	2.85 (1.53–5.33)**	209 (37)	—
Received Meningococcal Vaccine b
No	345 (84)	ref.	N/A	N/A	115 (28)	ref.
Yes	220 (94)	2.66 (1.44–4.90)**	N/A	N/A	116 (50)	2.27 (1.60–3.23)**
Received One or More Doses of HPV Vaccine
No	356 (86)	—	118 (28)	ref.	N/A	N/A
Yes	209 (90)	—	116 (50)	2.29 (1.60–3.27)**	N/A	N/A
Parent Characteristics
Age (years)
<40	121 (91)	—	37 (28)	ref.	45 (34)	—
40+	444 (86)	—	197 (38)	1.55 (0.98–2.45)	186 (36)	—
Sex
Female	532 (87)	—	224 (37)	—	220 (36)	—
Male	33 (87)	—	10 (26)	—	11 (29)	—
Race
Non-Hispanic White	418 (87)	—	167 (35)	—	179 (37)	—
Non-Hispanic African American	113 (86)	—	49 (37)	—	39 (30)	—
Other	34 (92)	—	18 (49)	—	13 (35)	—
Education Level
High School or Less	101 (83)	—	30 (25)	ref.	29 (24)	ref.
Some College or More	464 (88)	—	204 (39)	1.59 (0.99–2.56)	202 (38)	1.69 (1.04–2.73)*
Household Characteristics
Income
<$60,000	225 (87)	—	81 (31)	ref.	84 (32)	—
$60,000+	317 (88)	—	144 (40)	1.27 (0.89–1.83)	137 (38)	—
Not Reported	23 (85)	—	9 (33)	1.03 (0.42–2.51)	10 (37)	—
Urbanicity
Rural	276 (86)	—	109 (34)	—	123 (38)	—
Urban	289 (89)	—	125 (38)	—	108 (33)	—

Note: Multivariate binary logistic models did not include variables with dashes (—). HPV, human papillomavirus; OR, odds ratio; CI, confidence interval, ref., referent group; N/A, not applicable.

a Tetanus, diphtheria and acellular pertussis (Tdap) vaccine or tetanus and diphtheria toxoids (Td) vaccine.

b Meningococcal conjugate vaccine (MCV4) or meningococcal polysaccharide vaccine (MPS V4).

* p < 0.05,

** p < 0.01.